Portal:Medicine/Selected article/22, 2007

Add links
From Wikipedia, the free encyclopedia

Doxorubicin (trade name Adriamycin) or hydroxyldaunorubicin is a DNA-interacting drug widely used in chemotherapy. It is an anthracycline antibiotic and structurely closely related to daunomycin, and also intercalates DNA. It is commonly used in the treatment of a wide range of cancers.

The drug is administered by injection, and may be sold under the brand names Adriamycin PFS, Adriamycin RDF, or Rubex. Doxil is a liposome-encapsulated dosage form of doxorubicin made by Ben Venue Laboratories for Johnson & Johnson. The main benefits of this form are a reduction in cardiotoxicity. (More...)

Nominations • Archive
Retrieved from "https://en.wikipedia.org/w/index.php?title=Portal:Medicine/Selected_article/22,_2007&oldid=839612690"